These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19758314)

  • 1. Tumor necrosis factor-alpha processing inhibitor-1 inhibits skin fibrosis in a bleomycin-induced murine model of scleroderma.
    Terao M; Murota H; Kitaba S; Katayama I
    Exp Dermatol; 2010 Jan; 19(1):38-43. PubMed ID: 19758314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of tumor necrosis factor receptor p55 impairs collagen turnover in experimentally induced sclerodermic skin fibroblasts.
    Murota H; Hamasaki Y; Nakashima T; Yamamoto K; Katayama I; Matsuyama T
    Arthritis Rheum; 2003 Apr; 48(4):1117-25. PubMed ID: 12687556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin.
    Hayashi S; Ikeda M; Kitamura Y; Hamasaki Y; Hatamochi A
    J Dermatol Sci; 2012 Jul; 67(1):20-5. PubMed ID: 22486844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.
    Ohashi T; Yamamoto T
    Exp Dermatol; 2015 Sep; 24(9):698-702. PubMed ID: 25959255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?
    Kokot A; Sindrilaru A; Schiller M; Sunderkötter C; Kerkhoff C; Eckes B; Scharffetter-Kochanek K; Luger TA; Böhm M
    Arthritis Rheum; 2009 Feb; 60(2):592-603. PubMed ID: 19180474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice.
    Akashi K; Saegusa J; Sendo S; Nishimura K; Okano T; Yagi K; Yanagisawa M; Emoto N; Morinobu A
    Arthritis Res Ther; 2016 May; 18(1):113. PubMed ID: 27209208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation.
    Zhu L; Song Y; Li M
    J Dermatol Sci; 2015 Jan; 77(1):63-70. PubMed ID: 25465161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice.
    Song Y; Zhu L; Li M
    Clinics (Sao Paulo); 2013 Oct; 68(10):1350-7. PubMed ID: 24212843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local injection of latency-associated peptide, a linker propeptide specific for active form of transforming growth factor-beta1, inhibits dermal sclerosis in bleomycin-induced murine scleroderma.
    Nakamura-Wakatsuki T; Oyama N; Yamamoto T
    Exp Dermatol; 2012 Mar; 21(3):189-94. PubMed ID: 22188586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
    Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
    Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
    Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis.
    Suzuka T; Kotani T; Saito T; Matsuda S; Sato T; Takeuchi T
    Arthritis Res Ther; 2022 Oct; 24(1):228. PubMed ID: 36207753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
    Yamamoto T; Nishioka K
    Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma.
    Yamamoto T; Takagawa S; Katayama I; Yamazaki K; Hamazaki Y; Shinkai H; Nishioka K
    J Invest Dermatol; 1999 Apr; 112(4):456-62. PubMed ID: 10201529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model.
    Kavian N; Servettaz A; Mongaret C; Wang A; Nicco C; Chéreau C; Grange P; Vuiblet V; Birembaut P; Diebold MD; Weill B; Dupin N; Batteux F
    Arthritis Rheum; 2010 Nov; 62(11):3477-87. PubMed ID: 20583103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model.
    Stegemann A; Sindrilaru A; Eckes B; del Rey A; Heinick A; Schulte JS; Müller FU; Grando SA; Fiebich BL; Scharffetter-Kochanek K; Luger TA; Böhm M
    Arthritis Rheum; 2013 Mar; 65(3):792-804. PubMed ID: 23440693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of excessive collagen accumulation by human intravenous immunoglobulin treatment in a murine model of bleomycin-induced scleroderma.
    Kajii M; Suzuki C; Kashihara J; Kobayashi F; Kubo Y; Miyamoto H; Yuuki T; Yamamoto T; Nakae T
    Clin Exp Immunol; 2011 Feb; 163(2):235-41. PubMed ID: 21091669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing cleavage of Mer promotes efferocytosis and suppresses acute lung injury in bleomycin treated mice.
    Lee YJ; Lee SH; Youn YS; Choi JY; Song KS; Cho MS; Kang JL
    Toxicol Appl Pharmacol; 2012 Aug; 263(1):61-72. PubMed ID: 22687607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleomycin inhibits adipogenesis and accelerates fibrosis in the subcutaneous adipose layer through TGF-β1.
    Ohgo S; Hasegawa S; Hasebe Y; Mizutani H; Nakata S; Akamatsu H
    Exp Dermatol; 2013 Nov; 22(11):769-71. PubMed ID: 24118261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.